Evidence map›Paper›PMID 39596440›Full record

ArticleInternational journal of molecular sciences2024

Identification of a New Role of miR-199a-5p as Factor Implied in Neuronal Damage: Decreasing the Expression of Its Target X-Linked Anti-Apoptotic Protein (XIAP) After SCI.

Teresa Muñoz-Galdeano, David Reigada, Altea Soto, María Asunción Barreda-Manso, Pablo Ruíz-Amezcua, Manuel Nieto-Díaz, Rodrigo M Maza

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Teresa Muñoz-GaldeanoMolecular Neuroprotection Group, Research Unit, National Hospital for Paraplejics (SESCAM), 45071 Toledo, Spain.ORCID 0000-0003-3526-819X
David ReigadaMolecular Neuroprotection Group, Research Unit, National Hospital for Paraplejics (SESCAM), 45071 Toledo, Spain.ORCID 0000-0001-9041-0705
Altea SotoMolecular Neuroprotection Group, Research Unit, National Hospital for Paraplejics (SESCAM), 45071 Toledo, Spain.ORCID 0000-0002-4728-0543
María Asunción Barreda-MansoMolecular Neuroprotection Group, Research Unit, National Hospital for Paraplejics (SESCAM), 45071 Toledo, Spain.ORCID 0000-0003-4127-2101
Pablo Ruíz-AmezcuaMolecular Neuroprotection Group, Research Unit, National Hospital for Paraplejics (SESCAM), 45071 Toledo, Spain.
Manuel Nieto-DíazMolecular Neuroprotection Group, Research Unit, National Hospital for Paraplejics (SESCAM), 45071 Toledo, Spain.ORCID 0000-0002-7244-794X
Rodrigo M MazaMolecular Neuroprotection Group, Research Unit, National Hospital for Paraplejics (SESCAM), 45071 Toledo, Spain.ORCID 0000-0002-7249-9205

Funding

Council of Education, Culture, and Sports of the Regional Government of Castilla La Mancha SBPLY/17/000376Council of Education, Culture, and Sports of the Regional Government of Castilla La Mancha SBPLY/21/180501/000097Fundación Tatiana Pérez de Guzmán el Bueno 2017-2019
6 · The paper itself

Abstract

Spinal cord injury (SCI) results in a cascade of primary and secondary damage, with apoptosis being a prominent cause of neuronal cell death. The X-linked inhibitor of apoptosis (XIAP) plays a critical role in inhibiting apoptosis, but its expression is reduced following SCI, contributing to increased neuronal vulnerability. This study investigates the regulatory role of miR-199a-5p on XIAP expression in the context of SCI. Using bioinformatic tools, luciferase reporter assays, and in vitro and in vivo models of SCI, we identified miR-199a-5p as a post-transcriptional regulator of XIAP. Overexpression of miR-199a-5p significantly reduced XIAP protein levels, although no changes were observed at the mRNA level, suggesting translational repression. In vivo, miR-199a-5p expression was upregulated at 3 and 7 days post-injury, while XIAP expression inversely decreased in both neurons and oligodendrocytes, being particularly significant in the latter at 7 dpi. These findings suggest that miR-199a-5p contributes to the downregulation of XIAP and may exacerbate neuronal apoptosis after SCI. Targeting miR-199a-5p could offer a potential therapeutic strategy to modulate XIAP levels and reduce apoptotic cell death in SCI.

Indexed as

ApoptosisMicroRNAsNeuronsSpinal Cord InjuriesX-Linked Inhibitor of Apoptosis ProteinAnimalsGene Expression RegulationHumansMaleMiceOligodendrogliaRatsMicroRNAsMIRN199 microRNA, ratX-Linked Inhibitor of Apoptosis Proteinapoptotic cell deathmicroRNA-based therapiesneural cellsneuroprotectionspinal cord injuryXIAP

Identifiers

PMID39596440
PMCPMC11594351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.